What happened Hims & Hers warned customers of a data breach after unauthorized access to support tickets stored on a…
Hims & Hers Health (NYSE:HIMS) reported a data breach affecting a third party customer service platform that exposed some customers…
Kahn Swick & Foti, LLC, a prominent securities litigation law firm, has initiated an investigation into Hims & Hers Health,…
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law…
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &…
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &…
According to Hims and Hers, hackers broke into its third-party ticketing system between Feb. 4 and Feb. 7 and stole…
Telehealth giant Hims & Hers Health is warning that it suffered a data breach after support tickets were stolen from…
…
The breach was a result of a social engineering attack, where hackers tricked employees into granting system access.…
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100%…
Hims & Hers Health Inc NYSE:HIMS:…
If you were affected by the Hims & Hers data breach, you may be entitled to compensation.…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up…
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know…
Hims & Hers trades at $19.19 today, down 3.28%. See the latest price action and outlook amid heightened volatility.…
Hims & Hers data breach exposed customer names and contact info. If you were affected, learn what happened and your…
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
Hims & Hers Health trades at $19.96 today, down 3.88%. Latest signals suggest high volatility and short-term bearish pressure.…
Here’s why Hims & Hers (HIMS) stock could still deliver strong returns after a steep 2026 selloff.…
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…
In March 2026, Hims & Hers Health announced a collaboration with Novo Nordisk to offer eligible customers a broad range…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
Hims & Hers Health, Inc. HIMS is building a consumer-first digital healthcare platform that integrates diagnosis, treatment and fulfillment into…
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…
Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including Hims…
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…
Hims & Hers Health (NYSE:HIMS) has launched access to Novo Nordisk FDA-approved GLP-1 medications for eligible patients.The offering includes a…
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1%…
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1%…
Price-action only: Hims & Hers Health Inc. Class A (HIMS) movements set the tone for institutional models. Why (HIMS) Price…
New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von TD Cowen:Die Analysten von TD Cowen stufen die Aktie von Hims…
Recent performance snapshotHims & Hers Health (HIMS) has drawn investor attention after a mixed run, with the share price near…
Hims & Hers Health trades at $19.38 today, down 7.09%. Check out the latest price action and daily performance update.…
SG Americas Securities LLC raised its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 25.6%…
Hims & Hers Health Inc. stocks have been trading down by -7.02% amid cautious investor sentiment over leadership changes. Key…
TD Cowen lowered their target price on shares of Hims & Hers Health from $25.00 to $23.00 and set a…
Hims & Hers Health announced that, as of yesterday, it is providing direct access to Wegovy tablets, Wegovy injections,…
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
Hims & Hers Health shares rallied to ~$27 after the early-March Novo deal before resetting to ~$20. Click here to…
TD Cowen lowered the firm’s price target on Hims Hers to $23 from $25 and keeps a Hold rating…
Hims & Hers began by dismantling the barriers to essential care, turning stigmatized conversations into accessible, evidence-based solutions for hair…
Charlotte (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von BofA Securities:Allen Lutz, Analyst von BofA Securities, stuft die Aktie von Hims…